Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D

Pediatric Diabetes

Volumn 18, Issue 7, 2017, Pages 540-546

  DeBoer, Mark D ^a   Cherñavvsky, Daniel R ^a   Topchyan, Katarina ^a   Kovatchev, Boris P ^a   Francis, Gary L ^a   Breton, Marc D ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

artificial pancreas; exercise; heart rate; monitor; type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART RATE; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; ADVERSE DEVICE EFFECT; ALGORITHM; AMBULATORY MONITORING; ANALYSIS; ARTIFICIAL PANCREAS; BLOOD; CLINICAL TRIAL; EXERCISE TEST; HYPERGLYCEMIA; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; RISK; SEVERITY OF ILLNESS INDEX; VIRGINIA; WIRELESS COMMUNICATION;

ADOLESCENT; ALGORITHMS; BLOOD GLUCOSE; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; EXERCISE; EXERCISE TEST; FEMALE; GLYCATED HEMOGLOBIN A; HEART RATE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MONITORING, AMBULATORY; PANCREAS, ARTIFICIAL; RISK; SEVERITY OF ILLNESS INDEX; VIRGINIA; WIRELESS TECHNOLOGY;

EID: 84992478817     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12454     Document Type: Article

References (26)

1. Campbell M, Schatz D, Chen V, et al. A contrast between children and adolescents with excellent and poor control: the T1D exchange clinic registry experience. Pediatr Diabetes. 2013;15:110-117.
2. Guilfoyle SM, Crimmins NA, Hood KK. Blood glucose monitoring and glycemic control in adolescents with type 1 diabetes: meter downloads versus self-report. Pediatr Diabetes. 2011;12:560-566.
3. Hilliard ME, Wu YP, Rausch J, Dolan LM, Hood KK. Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. J Adolesc Health. 2013;52:28-34.
4. Cherñavvsky DR, DeBoer MD, Keith-Hynes P, et al. Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus. Pediatr Diabetes. 2016;17:28-35.
5. Ly TT, Breton MD, Keith-Hynes P, et al. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care. 2014;37:2310-2316.
6. Breton M, Farret A, Bruttomesso D, et al. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes. 2012;61:2230-2237.
7. Pivovarov JA, Taplin CE, Riddell MC. Current perspectives on physical activity and exercise for youth with diabetes. Pediatr Diabetes. 2015;16:242-255.
8. McMahon SK, Ferreira LD, Ratnam N, et al. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab. 2007;92:963-968.
9. Dohm GL. Invited review: regulation of skeletal muscle GLUT-4 expression by exercise. J Appl Physiol (1985). 2002;93:782-787.
10. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med. 1998;49:235-261.
11. Campbell MD, Walker M, Bracken RM, et al. Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care. 2015;3:e000085.
12. Breton MD, Brown SA, Karvetski CH, et al. Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes. Diabetes Technol Ther. 2014;16:506-511.
13. Kovatchev BP, Breton M, Man CD, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3:44-55.
14. Kovatchev B, Patek S, Dassau E, et al. Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol. 2009;3:1058-1065.
15. Hughes CS, Patek SD, Breton MD, Kovatchev BP. Hypoglycemia prevention via pump attenuation and red-yellow-green “traffic” lights using continuous glucose monitoring and insulin pump data. J Diabetes Sci Technol. 2010;4:1146-1155.
16. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236:E667-E677.
17. Grosman B, Dassau E, Zisser HC, Jovanovic L, Doyle FJ 3rd. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events. J Diabetes Sci Technol. 2010;4:961-975.
18. Swan KL, Dziura JD, Steil GM, et al. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care. 2009;32:240-244.
19. Brown SA, Kovatchev BP, Breton MD, et al. Multinight “bedside” closed-loop control for patients with type 1 diabetes. Diabetes Technol Ther. 2015;17:203-209.
20. Kovatchev BP, Renard E, Cobelli C, et al. Feasibility of outpatient fully integrated closed-loop control first studies of wearable artificial pancreas. Diabetes Care. 2013;36:1851-1858.
21. Kovatchev BP, Renard E, Cobelli C, et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care. 2014;37:1789-1796.
22. Younk LM, Mikeladze M, Tate D, Davis SN. Exercise-related hypoglycemia in diabetes mellitus. Expert Rev Endocrinol Metab. 2011;6:93-108.
23. Elleri D, Allen JM, Kumareswaran K, et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes. Diabetes Care. 2013;36:838-844.
24. Ben Brahim N, Place J, Renard E, Breton MD. Identification of main factors explaining glucose dynamics during and immediately after moderate exercise in patients with type 1 diabetes. J Diabetes Sci Technol. 2015;9:1185-1191.
25. Ly TT, Buckingham BA, DeSalvo DJ, et al. Day and night closed-loop control using the unified safety system in adolescents with type 1 diabetes at camp. Diabetes Care. 2016;39:e106-e107.
26. Beck RW, Tamborlane WV, Bergenstal RM, et al. The T1D exchange clinic registry. J Clin Endocrinol Metab. 2012;97:4383-4389.